You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Relebactam

Showing 1 - 19 of 19
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Obesity, Critical Illness Trial in Chicago (Imipenem/Cilastatin/Relebactam 1.25g)

Enrolling by invitation
  • Obesity
  • Critical Illness
  • Imipenem/Cilastatin/Relebactam 1.25g
  • Chicago, Illinois
    University of Illinois at Chicago
May 18, 2022

Sepsis Trial in Hartford (Imipenem-relebactam)

Completed
  • Sepsis
  • Hartford, Connecticut
    Hartford Hospital
Mar 29, 2022

Cystic Fibrosis, Pneumonia, Bacterial Trial in United States (Imipenem/Cilastatin/Relebactam)

Recruiting
  • Cystic Fibrosis
  • Pneumonia, Bacterial
  • Hartford, Connecticut
  • +6 more
Jan 3, 2023

Carbapenem-Resistant Enterobacteriaceae Infection, KPC, Gram-Negative Bacterial Infections Trial in Charlotte

Recruiting
  • Carbapenem-Resistant Enterobacteriaceae Infection
  • +3 more
  • Charlotte, North Carolina
    Carolinas Medical Center
Jun 16, 2022

Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor Trial in Houston (Cefepime, Imipenem/cilastatin-relebactam,

Recruiting
  • Hematopoietic and Lymphoid Cell Neoplasm
  • Malignant Solid Neoplasm
  • Houston, Texas
    M D Anderson Cancer Center
Jul 21, 2022

Resistance in Carbapenemase-producing Enterobacterales and

Enrolling by invitation
  • Bacterial Infections
  • Antibiotic Resistant Infection
  • No intervention
  • Rio De Janeiro, Brazil
    D'Or Institute for Research and Education (IDOR)
Mar 16, 2022

Hospital Acquired Bacterial Pneumonia or Ventilator-Associated Bacterial Pneumonia Trial (Combination of Imipenem/Cilastatin and

Not yet recruiting
  • Hospital Acquired Bacterial Pneumonia or Ventilator-Associated Bacterial Pneumonia
  • (no location specified)
Feb 2, 2022

Bacterial Pneumonia Trial (Imipenem, Relebactam, Cilastatin)

Completed
Has Results
  • Bacterial Pneumonia
  • (no location specified)
Apr 3, 2020

Complicated Intra-abdominal Infection, Complicated Urinary Tract Infection Trial in Japan (Imipenem+Cilastatin/Relebactam)

Completed
Has Results
  • Complicated Intra-abdominal Infection
  • Complicated Urinary Tract Infection
  • Nagoya, Aichi, Japan
  • +28 more
Jan 20, 2021

Hospital-Acquired Bacterial Pneumonia, Ventilator-Associated Bacterial Pneumonia Trial in Worldwide (IMI/REL FDC, PIP/TAZ FDC,

Completed
  • Hospital-Acquired Bacterial Pneumonia
  • Ventilator-Associated Bacterial Pneumonia
  • IMI/REL FDC
  • +2 more
  • Belo Horizonte, Minas Gerais, Brazil
  • +67 more
Jul 19, 2022

In Vitro Activity of Ceftolozane/Tazobactam and

Unknown status
  • Ceftolozane/Tazobactam
  • +2 more
  • Madrid, Spain
    HG Gregorio Marañón
Dec 10, 2019

Infectious Disease Trial (MK-7655, Imipenem + Cilastatin, Caffeine)

Completed
Has Results
  • Infectious Disease
  • (no location specified)
May 28, 2020

Suspected or Documented Gram-negative Bacterial Infection Trial in Worldwide (IMI/REL, Active Control)

Recruiting
  • Suspected or Documented Gram-negative Bacterial Infection
  • Tucson, Arizona
  • +64 more
Aug 18, 2022

Intra-abdominal Infections Trial (Relebactam 250 mg, Relebactam 125 mg, Imipenem/cilastatin)

Completed
Has Results
  • Intra-abdominal Infections
  • Relebactam 250 mg
  • +3 more
  • (no location specified)
Jun 7, 2019

Urinary Tract Infections, Pyelonephritis Trial (Relebactam 250 mg, Relebactam 125 mg, imipenem/cilastatin 500 mg)

Completed
Has Results
  • Urinary Tract Infections
  • Pyelonephritis
  • Relebactam 250 mg
  • +4 more
  • (no location specified)
Apr 26, 2019

Suspected or Documented Gram-negative Bacterial Infection Trial in Worldwide (IMI/REL FDC)

Completed
Has Results
  • Suspected or Documented Gram-negative Bacterial Infection
  • IMI/REL FDC
  • Little Rock, Arkansas
  • +32 more
Oct 28, 2021

Community-Acquired Pneumonia, Antimicrobial Stewardship, Point-of-Care Testing Trial in United States (Rapid Diagnostic Testing,

Recruiting
  • Community-Acquired Pneumonia
  • +2 more
  • Rapid Diagnostic Testing
  • Pharmacist-led de-escalation
  • Weston, Florida
  • +10 more
Jan 5, 2023

Use of New Antibiotics in Sweden

Recruiting
  • Multi-antibiotic Resistance
    • Gothenburg, Sweden
    • +6 more
    Feb 11, 2022

    Bacterial Infections Trial (Imipenem+Cilastatin/Relebactam, Colistimethate sodium (CMS), Imipenem+Cilastatin)

    Completed
    Has Results
    • Bacterial Infections
    • (no location specified)
    Oct 18, 2018